BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28383776)

  • 1. Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations.
    Helfrich O; Puech P; Betrouni N; Pinçon C; Ouzzane A; Rizk J; Marcq G; Randazzo M; Durand M; Lakroum S; Leroy X; Villers A
    J Magn Reson Imaging; 2017 Dec; 46(6):1786-1796. PubMed ID: 28383776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
    Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
    AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
    Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
    Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
    Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
    Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
    Woo S; Kim SY; Cho JY; Kim SH
    AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
    Johnston EW; Bonet-Carne E; Ferizi U; Yvernault B; Pye H; Patel D; Clemente J; Piga W; Heavey S; Sidhu HS; Giganti F; O'Callaghan J; Brizmohun Appayya M; Grey A; Saborowska A; Ourselin S; Hawkes D; Moore CM; Emberton M; Ahmed HU; Whitaker H; Rodriguez-Justo M; Freeman A; Atkinson D; Alexander D; Panagiotaki E; Punwani S
    Radiology; 2019 May; 291(2):391-397. PubMed ID: 30938627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
    Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
    [No Abstract]   [Full Text] [Related]  

  • 9. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
    Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
    Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
    Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-Dependent Diffusion in Prostate Cancer.
    Lemberskiy G; Rosenkrantz AB; Veraart J; Taneja SS; Novikov DS; Fieremans E
    Invest Radiol; 2017 Jul; 52(7):405-411. PubMed ID: 28187006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).
    Kitajima K; Takahashi S; Ueno Y; Yoshikawa T; Ohno Y; Obara M; Miyake H; Fujisawa M; Sugimura K
    J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
    Ueda Y; Takahashi S; Ohno N; Kyotani K; Kawamitu H; Miyati T; Aoyama N; Ueno Y; Kitajima K; Kawakami F; Okuaki T; Tsukamoto R; Yanagita E; Sugimura K
    J Magn Reson Imaging; 2016 Jan; 43(1):138-48. PubMed ID: 26119033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing structure of normal and malignant prostate tissue before and after radiation therapy with luminal water fraction and diffusion-weighted MRI.
    Carlin D; Orton MR; Collins D; deSouza NM
    J Magn Reson Imaging; 2019 Aug; 50(2):619-627. PubMed ID: 30589150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
    Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
    Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.
    Wibmer A; Hricak H; Gondo T; Matsumoto K; Veeraraghavan H; Fehr D; Zheng J; Goldman D; Moskowitz C; Fine SW; Reuter VE; Eastham J; Sala E; Vargas HA
    Eur Radiol; 2015 Oct; 25(10):2840-50. PubMed ID: 25991476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
    Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
    Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
    Waseda Y; Yoshida S; Takahara T; Kwee TC; Matsuoka Y; Saito K; Kihara K; Fujii Y
    J Magn Reson Imaging; 2017 Aug; 46(2):490-496. PubMed ID: 28152258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
    Sato C; Naganawa S; Nakamura T; Kumada H; Miura S; Takizawa O; Ishigaki T
    J Magn Reson Imaging; 2005 Mar; 21(3):258-62. PubMed ID: 15723379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.